AD-2022

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-2022, covering 2024-06-07 to 2024-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022 [Phase 3]